Cardeon Overview
- Founded
- 1996
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Cardeon General Information
Description
Developer of therapeutic drugs cardiac surgery patients. The company engages in research and development of therapeutic drugs fot the treatment of cardiac patients.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 10600 North Tantau Avenue
- Cupertino, CA 95014
- United States
+1 (408) 000-0000
Cardeon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2011 | 0000 | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series D) | 01-Dec-2001 | 0000 | 0000 | Completed | Generating Revenue |
Cardeon Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Wende Hutton | Self | Board Member | 000 0000 |
Cardeon Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ABS Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Apax Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Delphi Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Mayfield Fund | Venture Capital | Minority | 000 0000 | 000000 0 |